Quick answer: L-carnitine is most plausible for people with a real carnitine deficit or a context where trials show bigger effects: older adults, people with overweight or obesity, some metabolic-health populations, dialysis patients under medical care, and athletes using it for recovery over weeks, not days
FDA in 2014 approved the higher dose version of this compound (known as Saxenda) for chronic weight-management treatment
I share what our appointment actually looked like, what they were assessing, and the moment that really clicked for me when the doctor showed me what she might be seeing on a daily basis
Am J Physiol Endocrinol Metab 2010;299:E1076E1086 [DOI] [PMC free article] [PubMed] 18.Koehler JA, Baggio LL, Lamont BJ, Ali S, Drucker DJ